HR 2113
115th Congress
House
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Europe
European Union
Food and Drug Administration (FDA)
Prescription drugs
Speeding Access to Already Approved Pharmaceuticals Act of 2017
Introduced: April 20, 2017
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2017
Referred to the Subcommittee on Health.
Apr 20, 2017
Referred to the House Committee on Energy and Commerce.
Apr 20, 2017
Introduced in House
Plain-English summary
Speeding Access to Already Approved Pharmaceuticals Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1